Sangamo Therapeutics (NASDAQ:SGMO) reported its Q4 earnings results on Thursday, February 24, 2022 at 04:00 PM.

Here's what investors need to know about the announcement.

Earnings

Sangamo Therapeutics beat estimated earnings by 23.53%, reporting an EPS of $-0.26 versus an estimate of $-0.34.

Revenue was up $2.19 million from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.01 which was followed by a 0.73% increase in the share price the next day.

Here's a look at Sangamo Therapeutics's past performance:

To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.

This article was generated by Benzinga's automated content engine and reviewed by an editor.